Boots OTC divestiture
This article was originally published in The Tan Sheet
Executive Summary
Boots Group has provided a "memorandum of information" on its consumer unit, Boots Healthcare International, to parties who are "seriously interested" in purchasing the division, the firm said. The divestiture of the unit, which includes Clearasil skin care, Nurofen (ibuprofen) and Strepsils lozenges, is on track for completion by March 2006. Plans for the sale were announced in May (1"The Tan Sheet" May 30, 2005, p. 7)...